Ochre Bio

Clinical-stage biotechnology company developing RNA medicines for chronic liver diseases using its deep phenotyping platform to identify and validate therapeutic targets.

Location
Oxford, United Kingdom & New York, USA
Founded
2019
Investors
1
Categories
biotech, liver-disease, rna-medicines, phenomics

Investors

NameLocationTypeStagesPortfolio
Apollo Health VenturesDusseldorf, Germany / Boston, USAbiotech-focused
seedseries-a+1
15